What do clot busters commonly end with?

Clot busters, also known as thrombolytic agents, commonly have names that end with "ase." This suffix is derived from the terminology used in biochemistry, indicating the enzyme action of breaking down fibrin, which is crucial in the formation of clots. Thrombolytics work by activating the body's own fibrinolytic system and enhancing the breakdown of clots that obstruct blood vessels. The "ase" suffix reflects this enzymatic activity, as seen in common thrombolytics like alteplase, reteplase, and tenecteplase. Understanding this naming convention can help healthcare professionals quickly identify the pharmacological class of a medication. This knowledge is essential for safe patient care, especially in emergency situations where rapid treatment for conditions like myocardial infarction or stroke is necessary.